PDS Biotechnology Corp
PDSB· Nasdaq
PDSBPDS Biotechnology Corp
Filed May 11, 2022 · 10-Q · 41 days after period end · 0001140361-22-018571
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Net Income | -$8.47M | -$3.05M | -$3.99M | $6.82M |
| EPS Diluted | -$0.32 | -$0.14 | -$0.39 | $1.47 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PDS Biotechnology Corp · CIK 1472091 · Engraved from SEC EDGAR
ended Mar 31, 2022 · filed May 11, 2022 · 41 d after period end
